£m D1 0.0 (2,000.0) (4,000.0) (6,000.0) (8,000.0) Income & Expenditure OVERALL SUMMARY Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 COMMENTARY At the end of the second month of the new financial year, the <strong>Trust</strong>’s position is some £54k better than the £2.45 million planned deficit, at an actual position of £2.40 million deficit. Overall, this represents a £254k underspend against operational budgets <strong>and</strong> a £200k under-delivery of CIP targets. Income is £242k behind plan in Month 2 before CIPs as a result of under-performance against cardiac <strong>and</strong> non-contracted activity within the variable element of the contract <strong>and</strong> low levels of Private Patient, Education <strong>and</strong> Research income. Pay is underspent by £668k to Month 2 before CIPs with savings from vacancies exceeding discretionary pay costs in the majority of areas. (10,000.0) (12,000.0) (14,000.0) Actual Plan Non Pay expenditure is overspent by £154k before CIPs. Drug expenditure remains higher than plan, with 50% of the excluded drugs overspend being re-imbursed by Commissioners. Medical <strong>and</strong> Surgical Supplies expenditure is lower than plan reflecting lower than planned activity levels in some high cost areas. DETAILED ANALYSIS PLAN Plan Actual Variance MONTH PERFORMANCE Budget Actual Variance Variance Variance DIRECTORATE Apr-12 (941) (913) (28) Income (34,011) (33,210) 801 in-month YTD May-12 (2,455) (2,401) (54) Pay expenditure 21,116 20,389 (727) Cardiothoracics 43 (97) Jun-12 (3,580) Non-pay expenditure 12,580 12,439 (141) Children & Young People's Health 23 52 Jul-12 (4,683) Depreciation <strong>and</strong> interest 1,829 1,869 40 Emergency Services 26 39 Aug-12 (5,869) NET DEFICIT/(SURPLUS) 1,514 1,488 (26) Gastro, Surgery <strong>and</strong> Renal Services 119 184 Sep-12 (7,052) Head & Neck Surgery 60 81 Oct-12 (8,132) YTD PERFORMANCE Budget Actual Variance Medical Specialties 153 222 Nov-12 (9,040) Income (67,945) (66,906) 1,039 Neurosciences 12 30 Dec-12 (9,923) Pay expenditure 41,978 40,859 (1,119) Ophthalmology 50 68 Jan-13 (11,043) Non-pay expenditure 24,764 24,775 10 Oncology & Blood (51) 286 Feb-13 (11,581) Depreciation <strong>and</strong> interest 3,658 3,674 16 Orthopaedics & Rheumatology (11) 126 Mar-13 (13,000) NET DEFICIT/(SURPLUS) 2,455 2,401 (54) Reproductive Health <strong>and</strong> Womens Srvs 97 142 Anaesthetics Pain <strong>and</strong> Critical Care (24) (62) Pharmacy (37) 9 Health Science & Technology (42) (45) Clinical Support Services 95 94 Chief Executive (2) 29 Information <strong>and</strong> Planning (15) (54) Director of Finance (53) (72) Director of Human Resources (40) (88) Site Services 126 169 Medical Director (36) (92) <strong>Trust</strong> Wide (490) (1,077) All figures are recorded in £000s Research <strong>and</strong> Development (30) 3 TOTAL (26) (54) 15
D2 Cost improvement programme (CIP) 3,500,000 3,000,000 2,500,000 2,000,000 Red Amber Green Delivered Plan OVERALL SUMMARY COMMENTARY Plans have been developed in order to deliver up to £25.7m of savings. Following the decision by the Board to allow non-recurring CIPs only in exceptional cases, £1.6 million of Non-Recurring Directorate CIPs have been removed from the position reported at Month 1. At present, £23.1m of the plans are for recurring schemes, with a full year effect of £26.8million. The risk assessed value of schemes is currently £19.7million <strong>and</strong> additional schemes will be required to ensure achievement of the target for the year. Further work is underway to assess progress with delivery of schemes <strong>and</strong> to review forecasts of delivery at a more detailed level. 1,500,000 1,000,000 500,000 0 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Oct-13 Nov-13 Dec-13 Jan-14 Feb-14 Mar-14 DETAILED ANALYSIS FORECAST Plan Delivered Green Amber Red PROGRAMME SUMMARY Target Forecast Variance Apr-13 1,154,016 1,212,409 Directorate Schemes - Clinical 11,731,000 5,421,149 (6,309,851) May-13 1,256,484 998,339 0 Directorate Schemes - Corporate 1,346,000 1,101,857 (244,143) Jun-13 1,228,018 432,257 872,317 291,983 117,933 Outpatient Efficiency 451,000 451,000 0 Jul-13 1,722,667 370,503 866,056 315,529 122,759 Clinical Administration 1,294,000 1,201,860 (92,140) Aug-13 1,751,560 378,063 898,765 231,954 122,759 Medicines Management 1,300,000 1,299,999 (1) Sep-13 1,752,583 379,492 898,765 446,239 122,759 Theatre Efficiency 360,000 360,000 0 Oct-13 2,502,879 379,492 1,390,264 984,521 159,093 Beds 0 0 0 Nov-13 2,510,179 379,491 1,149,164 991,910 159,093 Workforce 4,340,000 3,680,498 (659,502) Dec-13 2,512,768 379,489 1,149,164 999,299 159,093 Medical Job Planning 500,000 500,000 0 Jan-14 2,517,768 379,489 1,149,164 1,007,042 159,093 Non <strong>NHS</strong> Income 1,280,000 1,279,999 (1) Feb-14 2,567,890 379,489 1,154,289 1,002,042 159,093 Non Pay 2,000,000 2,000,000 0 Mar-14 2,523,189 379,566 1,409,484 1,003,263 159,097 Finance Solutions 1,500,000 2,224,720 724,720 TOTAL 24,000,000 6,048,079 10,937,435 7,273,783 1,440,770 Reserve Slippage 7,000,000 6,178,985 (821,015) 25,700,067 Adjustment for stretch targets (9,102,000) 0 9,102,000 TOTAL 24,000,000 25,700,067 1,700,067 16
- Page 1 and 2:
Trust Board Friday 5 July 2013, 9.0
- Page 3 and 4:
Members of Plymouth Hospitals NHS T
- Page 5 and 6:
Item 3 observer. The Chairman requi
- Page 7 and 8:
Item 3 Board oversight of contribut
- Page 9 and 10:
Item 3 the Board next month. • Th
- Page 11 and 12:
Item 3 been involved and there was
- Page 13 and 14:
Item 3 continuing to build. Mr Babe
- Page 15 and 16:
Item 3 to Norovirus, Professor Lewi
- Page 17 and 18:
Item 3 • Careful communication of
- Page 19 and 20:
Item 3 • Approved the writing off
- Page 21 and 22:
Updated: prior to July Board Item 4
- Page 23 and 24:
Updated: prior to July Board Item 4
- Page 25 and 26:
Item 8 Quality Impact Assessment Pa
- Page 27 and 28: Item 8 3.2 Quarterly Summary Hospit
- Page 29 and 30: Item 8 4.4 Monthly Proportion of Pa
- Page 31 and 32: Item 8 Inpatient falls are currentl
- Page 33 and 34: Item 8 REI signage PALS were contac
- Page 35 and 36: Item 8 Complaints received listed b
- Page 37 and 38: Item 8 The graphs below illustrate
- Page 39 and 40: Item 8 5.5 Friends and Family Test
- Page 41 and 42: Item 8 1. Pressure Ulcers (EoC) 2.
- Page 43 and 44: Item 8 Observations The essence of
- Page 45 and 46: Item 8a SUMMARY REPORT Trust Board
- Page 47 and 48: Annex 2 Item 8a Summary of Serious
- Page 49 and 50: Item 9 Key Recommendations The Trus
- Page 51 and 52: Item 9 Effective Care (Section B2 o
- Page 53 and 54: Item 9 Description 31 days from 'de
- Page 55 and 56: Item 9 4.6 Non Elective Activity is
- Page 57 and 58: Item 9 Summary of performance excep
- Page 59 and 60: Item 9 Ensure that all patients adm
- Page 61 and 62: Item 9 Forecast Significant progres
- Page 63 and 64: Item 9 Update on previous actions C
- Page 65 and 66: Contents EXECUTIVE SUMMARY D FINANC
- Page 67 and 68: B1 Safe care Description Hospital S
- Page 69 and 70: Response Rate Recommender Score B3
- Page 71 and 72: B5 Other safety & quality metrics D
- Page 73 and 74: C2 Non-Elective Activity Descriptio
- Page 75 and 76: C4 Referral To Treatment (RTT) Desc
- Page 77: C6 Other access & activity metrics
- Page 81 and 82: D4 Cash Management Description Revi
- Page 83 and 84: E1 Staffing numbers Description Est
- Page 85 and 86: E3 Sickness absence PERFORMANCE IND
- Page 87 and 88: Risk Rating F2 Monitor's Financial
- Page 89 and 90: Item 10 DETAILED REPORT Trust Board
- Page 91 and 92: Item 10 4. Key Issues for the Board
- Page 93 and 94: Item 11 SUMMARY REPORT Trust Board
- Page 95 and 96: Item 11 DETAILED REPORT Trust Board
- Page 97 and 98: Item 11 • Challenge in respect of
- Page 99 and 100: Item 11 Over the past two years, me
- Page 101 and 102: Item 11 Getting it Right Charter An
- Page 103 and 104: Item 11 Outcome of review with exte
- Page 105 and 106: Item 11 Learning Disabilities Natio
- Page 107 and 108: Item 11 Peer Review 2.5 Peer Review
- Page 109 and 110: Item 12 Next Steps 1. Conversation
- Page 111 and 112: Item 12 2. Board Inclusion Developm
- Page 113 and 114: Item 12 EDS Grades and E & D Object
- Page 115 and 116: Item 12 Plymouth Hospitals Trust -
- Page 117 and 118: Item 12 3.6 The workforce is suppor
- Page 119 and 120: Item 13 Key Recommendations The Tru
- Page 121 and 122: Item 13 Telephone conversations.
- Page 123 and 124: Item 13 19. The Medical Director ha
- Page 125 and 126: Item 14 SUMMARY REPORT Trust Board
- Page 127 and 128: Item 15 incident investigations to
- Page 129 and 130:
Item 15, Annex 1 3. Review of Actio
- Page 131 and 132:
Item 15, Annex 1 • Top three issu
- Page 133 and 134:
Item 15, Annex 1 The Chair asked SS
- Page 135 and 136:
Item 16 COMMITTEE MINUTES Finance,
- Page 137 and 138:
Item 16 pay and staffing, highlight
- Page 139 and 140:
Item 16 • PACS contract - likely
- Page 141 and 142:
Item 17 Terms and Conditions of Emp
- Page 143 and 144:
Item 17, Annex 1 29/2013 Minutes an
- Page 145 and 146:
Item 17, Annex 1 31/2013 Francis Re
- Page 147 and 148:
Item 18 SUMMARY REPORT Trust Board
- Page 149 and 150:
Item 18 Next Steps The Audit Commit
- Page 151 and 152:
Item 18, Annex 1 Matters arising 4/
- Page 153 and 154:
Item 18, Annex 1 time to embed and
- Page 155 and 156:
Item 18, Annex 1 Payroll & Expenses
- Page 157 and 158:
Item 18, Annex 1 The Committee note
- Page 159 and 160:
Item 18, Annex 1 Going Concern Revi
- Page 161:
Item 18, Annex 1 if Internal Audit